Tieken Kelsey, Paramasivan Ameena Madan, Goldner Whitney, Yuil-Valdes Ana, Fingeret Abbey L
AACE Clin Case Rep. 2020 Sep 26;6(1):e14-e18. doi: 10.4158/ACCR-2019-0132. eCollection 2020 Jan-Feb.
Graves disease is the most common cause of thyrotoxicosis. Medical management is the first-line treatment but may be contraindicated or ineffective. In patients with severe, refractory thyrotoxicosis therapeutic plasma exchange (TPE) may be indicated as a bridge to thyroidectomy.
We present 3 cases of thyrotoxicosis refractory to medical management that were successfully treated with TPE and subsequent total thyroidectomy, and provide an analysis of the response to therapy via a change in free thyroxine (fT4) levels throughout their treatment course.
The average change in fT4 per liter of fluid exchanged was 0.37 ng/dL (SD = 0.08) and the average percentage change of fT4 after each treatment was 20.7% (SD = 8.28). The mean decrease in fT4 after 4 TPE treatments was 57.4%. All patients successfully underwent total thyroidectomy without complication and were discharged from the hospital.
TPE should be considered for thyrotoxic patients with severe hyperthyroidism or thyroid storm refractory to medical management or contraindications to antithyroid drugs who need a bridge to total thyroidectomy. In these cases, TPE was a safe and effective treatment that enabled definitive management with thyroidectomy and may be considered in other patients with severe refractory hyperthyroidism or thyrotoxicosis.
格雷夫斯病是甲状腺毒症最常见的病因。药物治疗是一线治疗方法,但可能存在禁忌或无效。对于严重的难治性甲状腺毒症患者,治疗性血浆置换(TPE)可作为甲状腺切除术的过渡治疗。
我们报告3例药物治疗难治的甲状腺毒症患者,经TPE及随后的全甲状腺切除成功治疗,并通过分析其治疗过程中游离甲状腺素(fT4)水平的变化来评估治疗反应。
每置换1升液体,fT4的平均变化为0.37 ng/dL(标准差=0.08),每次治疗后fT4的平均变化百分比为20.7%(标准差=8.28)。4次TPE治疗后fT4的平均下降幅度为57.4%。所有患者均成功接受全甲状腺切除术,无并发症发生并出院。
对于药物治疗难治或对抗甲状腺药物有禁忌且需要过渡到全甲状腺切除术的严重甲亢或甲状腺危象的甲状腺毒症患者,应考虑TPE治疗。在这些病例中,TPE是一种安全有效的治疗方法,可实现甲状腺切除术的确定性治疗,也可考虑用于其他严重难治性甲亢或甲状腺毒症患者。